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AdhesionCells anchor to substrates by binding to extracellularmatrix (ECM). In addition to this anchoring function however,
cell–ECM binding is a mechanism for cells to sense their surroundings and to communicate and coordinate
behaviour amongst themselves. Several ECM molecules and their receptors play essential roles in muscle
development and maintenance. Defects in these proteins are responsible for some of the most severe muscle
dystrophies at every stage of life from neonates to adults. However, recent studies have also revealed a role of cell–
ECM interactions at much earlier stages of development as skeletal muscle forms. Here we review which ECM
molecules are present during the early phases of myogenesis, how myogenic cells interact with the ECM that
surrounds themand the potential consequencesof those interactions.We conclude that cell–ECM interactions play
signiﬁcant roles during all stages of skeletalmuscle development in the embryo and suggest that this “extracellular
matrix dimension” should be added to our conceptual network of factors contributing to skeletal myogenesis.Animal, Faculdade de Ciências,
+351 217500028.
ir), mederies@fc.ul.pt
bajanca@kcl.ac.uk (F. Bajanca).
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Skeletal muscle development is a highly regulated process that
depends on the interplay between a panoply of cell-autonomous and
extrinsic factors. Mesodermal cells commit to the myogenic lineage at
certain times and places in the embryo, then differentiate and fuse to
form multinucleated myoﬁbres with contractile activity (Biressi et al.,
2007; Buckingham, 2001). How undifferentiated cells become muscle
cells at the correct time and in the appropriate places in the embryo has
been addressed for more than a century (Bardeen, 1900; Williams,
1910). In the last two decades, gene targeting in mice, bead technology
for local delivery of growth factors and recombinant gene transfer in
chick embryos and mutagenesis or morpholino technology in zebraﬁsh
have lead to breakthroughs in our understanding of skeletal muscle
development at several levels (Biressi et al., 2007; Bryson-Richardson
and Currie, 2008; Buckingham, 2006; Sambasivan and Tajbakhsh, 2007;
Scaal and Christ, 2004). These include how the myogenic regulatory
factors (MRFs), transcription factors of the helix-loop-helix family and
master regulators of skeletal myogenesis, control skeletal musclecommitment and differentiation and how growth factor signalling
acts on theseMRFs, promotingor inhibiting skeletalmyogenesis (Biressi
et al., 2007; Buckingham, 2006). The embryonic origin of myogenic
precursors has recently been identiﬁed and efforts are nowongoing into
studying how these precursors give rise to the different types of
myoblasts (Biressi et al., 2007; Buckingham and Relaix, 2007). It is
gradually being appreciated that skeletal muscle development in vivo is
muchmore complex and tightly regulated thanmyoblast differentiation
and fusion in vitro (Gullberg et al., 1998;McLennan andKoishi, 2002). In
addition, even thoughwehave accumulatedconsiderable knowledgeon
the process of in vivo skeletal myogenesis itself and the role played by
transcription factors and growth factor-induced signalling pathways,
we know comparatively much less about the role of the extracellular
matrix (ECM) in the events that lead mesodermal cells to enter the
myogenic lineage and progressively develop into functional muscle
ﬁbres.
Our objective in this review is to revisitwhatweknowabout theECM
during embryonic myogenesis in the vertebrate embryo by presenting
the available data within the current framework of skeletal muscle
development in vivo. Wewill cover the early stages of myogenesis using
the mouse embryo as a model, but also often referring to the avian
systems and occasionally also to zebraﬁsh, whenever appropriate. We
will address issues of induction and maintenance of myogenic
precursors, their commitment, translocation and differentiation as well
as the formation of multinucleated myotubes.
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The extracellular matrix and its relationship with cells in the embryo
The most basic role of the ECM (and the only one recognised for
decades) is toprovidea supportive scaffold for cells and tissues,promoting
cell aggregation and providing a substrate for cell migration (Frantz et al.,
2010). ECM assembly and deposition and cell–ECM interactions are the
basic motors for polarising cells, separating cell types and supporting
short- and long-range cell migrations, consequently shaping the tissues
within the developing embryo (Goody and Henry, 2010; Ingber, 2006;
Larsenet al., 2006;Rozario andDeSimone, 2010). TheECMis, however, far
frombeing a static entity. It ismodiﬁed, degraded and reassembledduring
development and disease as well as during homeostasis (Daley et al.,
2008; Frantz et al., 2010; Ghajar and Bissell, 2008). The ECM directly
inﬂuences cell behaviour through ECM-speciﬁc receptors on the cell
surface. By binding to ECMs through these receptors, cells sense their
surroundings and actively modulate their behaviour depending on its
composition (Daley et al., 2008; Ghajar and Bissell, 2008; Ingber, 2006).
Apart from its direct effects, the ECM can also inﬂuence cell
behaviour indirectly. The ECM can sequester and store soluble growth
factors andpresent them togrowth factor receptors on the cell surface at
developmentally and/or physiologically relevant times (Kirkpatrick and
Selleck, 2007; Rozario and DeSimone, 2010; Selleck, 2000). In this way
the ECM may contribute to the establishment of gradients of secreted
signallingmolecules or can concentrate these factors around certain cell
types and facilitate their binding to their receptors (Kirkpatrick and
Selleck, 2007; Larsen et al., 2006; Ruoslahti et al., 1992; Selleck, 2000;
Schambony et al., 2004; Streuli, 1999). Cell-controlled degradation of
the ECM can also release fragments of ECM bound to growth factors and
facilitate their binding to signalling receptors on the cell surface
(Whitelock et al., 2008).
Thus the ECM and cell–ECM engagement through cell surface
receptors not only provides mechanical support, but also signals to the
interior of the cell affecting gene expression and such diverse cellular
responses as proliferation, polarisation, migration, differentiation,
survival andapoptosis, eitherdirectly throughECMreceptors, or through
crosstalk with growth factor signalling pathways (Frantz et al., 2010;
Ingber, 2006; Larsen et al., 2006; Rozario and DeSimone, 2010).
Components of the extracellular matrix
The ECM is composed of a variety of glycoproteins and polysac-
charide molecules assembled into a macromolecular network (Fig. 1).
Both the protein-rich (e.g. collagens, ﬁbronectin, laminins, and
tenascins) and polysaccharide-rich (glycosaminoglycans and proteo-
glycans)molecules of the ECM are secreted by cells and are assembled
into an organised meshwork, adapted to the functional requirements
of the particular tissue (Frantz et al., 2010). There are twomajor types
of ECMs, the interstitial and pericellular matrices. The ﬁrst type is the
matrix of connective tissue (Fig. 1) and consists of a tissue- and age-
speciﬁc mixture of a variety of collagen types, elastins, ﬁbronectin,
tenascins amongst others, as well as proteoglycans and glycosami-
noglycans (Frantz et al., 2010). Pericellular matrices are matrices in
close contact with cells and that have a different molecular
composition than the surrounding interstitial matrix. The prototype
of a pericellular matrix is the basement membrane of epithelial,
endothelial, muscle, nerve, and fat cells (Fig. 1). Basementmembranes
are sheet-like structures, primarily composed of laminins, collagen
type IV, nidogen (entactin), and perlecan (a heparan sulphate
proteoglycan), and they separate these cell types from the surround-
ing connective tissue (LeBleu et al., 2007). Laminins are the best
studied of these basement membrane components. They are com-
posed of a combination of three chains (α, β and γ; Fig. 1) which exist
in different forms, forming at least 16 different laminins (Table 1).
Basement membranes are present in the embryo from the earlieststages of development (Colognato and Yurchenco, 2000; Ekblom
et al., 2003; Yurchenco et al., 2004) and are essential for embryo
viability past E5.5 (Smyth et al., 1999). Another important type of
pericellular matrix is the ﬁbronectin matrix of embryonic tissues.
Fibronectin matrices are formed by an active cell-based process,
where the globular ﬁbronectin molecule is unfolded by speciﬁc
integrin receptors exposing ﬁbronectin–ﬁbronectin binding sites
within the molecule and leading to crosslinking and the assembly of
a ﬁbrillar matrix (Mao and Schwarzbauer, 2005; Singh et al., 2010).
Fibronectin has traditionally been considered as a component of the
mesenchymal ECM, promoting mesenchymal behaviours such as cell
migration. However it is becoming increasingly clear that ﬁbronectin
is far more versatile than that (Armstrong and Armstrong, 2000). For
example, during development pericellular ﬁbronectin matrices play
crucial roles in the polarisation and physical containment of
epitheloid cells as well as in tissue compartmentalization (e.g.
Marsden and DeSimone, 2001; Martins et al., 2009; Sakai et al.,
2003; Trinh and Stainier, 2004; Zhou et al., 2008).
ECM receptors
Cells bind to the ECM through speciﬁc cell surface receptors, the
best studied being dystroglycan, syndecans and integrins.
Dystroglycan (Fig. 1) is an ECM receptor, ﬁrst identiﬁed in skeletal
muscle. It is a transmembraneprotein, composed of two subunits (α and
β dystroglycan) synthesised from a single gene (Dag1). It forms a
multimeric transmembrane molecular complex with other molecules
which, through binding to laminin 211, is believed to confer stability to
myotubesduringmuscle contraction (MooreandWinder, 2010).Defects
in the glycosylation of the dystroglycan molecule, mutations in
dystrophin, a member of the complex, or in the laminin α2 chain
(Lama2) leads to various forms of muscular dystrophy (Huh et al., 2005;
Moore andWinder, 2010). Apart from its major role in skeletal muscle,
dystroglycan is also expressed in a variety of other tissues (epithelia,
nervous system etc.) where it links the cytoskeleton to laminin and is
thought to play a role in branchingmorphogenesis, cell polarisation and
neuromuscular junction formation amongst others (Moore andWinder,
2010). The early lethality of Dag1-null embryos (E5.5) points to an
essential role for dystroglycan in the formation and/or maintenance of a
subset of embryonic basement membranes (Williamson et al., 1997).
Syndecans are membrane-intercalated proteoglycans containing a
protein core bound to heparan sulphate and chondroitin sulphate
glycosaminoglycan chains (Couchman, 2003; Rapraeger, 2001). There
are four different syndecans in mammals (syndecans 1–4). Syndecans
can bind ECM molecules directly, but they also bind growth factors
through their glycosaminoglycan chains and they crosstalk with
integrins both at the ligand binding and signalling level (Morgan et al.,
2007). Syndecanshavebeen implicated in adultmyogenesis andmuscle
regeneration (Cornelison et al., 2004).
By far themost versatile andbest studied of the ECMreceptors are the
integrins (Barczyk et al., 2010; Hynes, 1992; Legate et al., 2009; van der
Flier and Sonnenberg, 2001). Integrins (Fig. 1) are heterodimeric
glycoproteins composed of an α subunit non-covalently bound to a β
subunit, both containing extracellular, transmembrane and cytoplasmic
domains. Inmammals, a total of 18α subunits and8β subunitshavebeen
described to date. These combine into 24 different integrins (Table 2),
each combination ofα andβ subunits forming a receptor for one ormore
ECMmolecule. In some cases, integrinsmediate cell–cell interactions and
can even bind soluble molecules (Barczyk et al., 2010; van der Flier and
Sonnenberg, 2001). At least 8 different α chains and two different β
chains are expressed during skeletal muscle development (Table 3).
Integrins on the cell surface are allosteric proteins that exist in low,
primed and high afﬁnity states (Askari et al., 2009; Hynes, 2002). Their
transitionbetween those states is inﬂuencedbyavarietyof factors, suchas
ligand engagement and the binding of intracellular proteins to their
cytoplasmic domains (Askari et al., 2009; Legate et al., 2009). Integrin–
Fig. 1. The ECM and its relationship to cells. The ECM can be divided into interstitial and pericellular matrices. The interstitial matrix is illustrated in the central panel and contains
interspersed mesenchymal cells (blue). The major ECM components are shown in the lower panel and are ﬁbrillar collagens (typiﬁed as collagen type I), a variety of proteoglycans and
glycosaminoglycans (PGs/GAGs), tenascin, ﬁbronectin, amongst others. Of these, collagens, tenascin and ﬁbronectin interact with cells through integrins. Pericellular matrices are
illustrated in the central panel as thebasementmembranes (lightgreen sheets) liningepithelia (browncells) andbloodvessels (red cells). Themajor basementmembrane components are
represented in the upper half of the panel, consisting of laminins, nidogen, perlecan and collagen type IV. Of these, collagen type IV binds to certain integrin receptors on the cell surface
whilst laminin engages integrins and dystroglycan (DG). Laminins and collagen type IV assemble into a sheet-like network which also incorporates nidogen and perlecan.
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the afﬁnity of its cytoplasmic domain for the proteins involved in
numerous signalling pathways, whilst interaction of cytoplasmic proteins
to their intracellular domain can modulate their ligand afﬁnity (Askari
et al., 2009; Danen and Sonnenberg, 2003; Hynes, 2002; Legate et al.,
2009). Integrins also link to the actin (or intermediate ﬁlament)
cytoskeleton through a variety of adaptor proteins, thus serving as a
mechanosensor of the extracellular environment (Ingber, 2006; Schwartz
and DeSimone, 2008). Which signalling pathways are activated upon
ligand binding depends not only on the nature of the integrin and the
ligand, but also on the cell type and cell context (Barczyk et al., 2010).
Thus, apart from their direct signalling function, integrins can also feed
into pathways activated by growth factors enhancing or inhibiting their
effect (Comoglio et al., 2003; Danen and Sonnenberg, 2003; ffrench-
Constant and Colognato, 2004;Walker et al., 2005). For example, integrin
linked kinase (ILK) and its associatedmolecules (PINCHs andparvins) can
inhibit GSK3β thus enhancing Wnt signalling, can activate Akt thus
synergizing with PI3K signalling, and canmodulate the activity of several
RhoGTPases so affecting cellmotility (Legate et al., 2006;Wickströmet al.,
2010). Another common integrin target, focal adhesion kinase (FAK) can
activate MAP kinase and ERK and is a regulator of Rho GTPases (Schaller,
2010; Yee et al., 2008). Furthermore, the ECM can augment signalling
downstream of growth factor receptors by concentrating signalling
substrates in close proximity of these receptors and integrin-mediatedadhesion to ECM can even cluster and activate growth factor receptors in
the absence of their ligand (Comoglio et al., 2003;Danen and Sonnenberg,
2003; ffrench-Constant and Colognato, 2004; Walker et al., 2005).
In this way, integrin signalling has been shown to modulate
proliferation, polarisation, migration, differentiation, survival and
apoptosis. In agreement with a role in such a variety of cell behaviours,
integrins are widely expressed, with practically all cells in the embryo
and adult organism possessing their cell type- and/or developmental
stage-speciﬁc integrin repertoire. Furthermore, integrins are stable cell
surface proteinswhich can rapidly change their afﬁnity for extracellular
ligands and their connections to intracellular effectors (Askari et al.,
2009;Hynes, 2002; Legate et al., 2009). Thus changes in integrin activity
are not dependent on de novo transcription; in fact it is important for the
developmental biologist to keep in mind that the absence of mRNA
expression for a pair of integrin subunits in a tissue at a certain timedoes
not necessarily mean that the protein is not present, since transcription
might have occurred earlier in the life of that particular cell.
The extracellular matrix and skeletal muscle development
Somitogenesis and the establishment of the dermomyotome
All trunk and limb skeletalmuscles of vertebrates are derived from the
paraxial mesoderm, located on each side of the neural tube, extending
Table 1
The laminins.
Laminin Old laminin
nomenclature
Chain
composition
Genes
Laminin 111 Laminin-1 α1β1γ1 Lama1 Lamb1 Lamg1
Laminin 121 Laminin-3 α1β2γ1 Lama1 Lamb2 Lamg1
Laminin 211 Laminin-2 α2β1γ1 Lama2 Lamb1 Lamg1
Laminin 221 Laminin-4 α2β2γ1 Lama2 Lamb2 Lamg1
Laminin 213 Laminin-12 α2β1γ3 Lama2 Lamb1 Lamg3
Laminin 212a – α2β1γ2 Lama2 Lamb1 Lamg2
Laminin 222a – α2β2γ2 Lama2 Lamb2 Lamg2
Laminin 311 Laminin-6 α3Aβ1γ1 Lama3A Lamb1 Lamg1
Laminin 321 Laminin-7 α3Aβ2γ1 Lama3A Lamb2 Lamg1
Laminin 332 Laminin-5 α3Aβ3γ2 Lama3A Lamb3 Lamg2
Laminin 3B32 Laminin-5B α3Bβ3γ2 Lama3B Lamb3 Lamg2
Laminin 333 – α3Aβ3γ3 Lama3A Lamb3 Lamg3
Laminin 411 Laminin-8 α4β1γ1 Lama4 Lamb1 Lamg1
Laminin 421 Laminin-9 α4β2γ1 Lama4 Lamb2 Lamg1
Laminin 423 Laminin-14 α4β2γ3 Lama4 Lamb2 Lamg3
Laminin 511 Laminin-10 α5β1γ1 Lama5 Lamb1 Lamg1
Laminin 521 Laminin-11 α5β2γ1 Lama5 Lamb2 Lamg1
Laminin 522a – α5β2γ2 Lama5 Lamb2 Lamg2
Laminin 523 Laminin-15 α5β2γ3 Lama5 Lamb2 Lamg3
Adapted from: Aumailley et al., 2005; Durbeej, 2010.
a Existence proposed.
Table 2
The integrins and their ligands.
Integrin Genes ECM ligand Soluble
ligand
Cell surface
ligand
α1β1 Itga1
Itgb1
Col I/IV/IX; Ln
(α1, α2 chain)
Semaphorin
7A
α2β1 Itga2
Itgb1
Col I/IV/IX; Ln
(α1, α2, α5 chain)
E-cadherin,
endorepillin
α3β1 Itga3
Itgb1
Ln (α3, α5 chain);
Tsp
α4β1 Itga4
Itgb1
Fn pp-vWF;tTG;
FXIII
VCAM-1
α4β7 Itga4
Itgb7
Fn VCAM-1;
MadCAM
α5β1 Itga5
Itgb1
Fn tTG; endostatin ADAM-15
α6β1 Itga6
Itgb1
Ln (α1, α2, α3, α4,
α5 chain)
ADAM-2,9
α6β4 Itga6
Itgb4
Ln (α3, α5 chain)
α7β1 Itga7
Itgb1
Ln (α1, α2, α4, α5
chain)
α8β1 Itga8
Itgb1
Fn; Vn; Nn; Tn
α9β1 Itga9
Itgb1
Tn; Col I; Opn; Ln
(α1 chain)
pp-vWF; tTG; FXIII;
NGF; VEGF; angiostatin
VCAM-1;
ADAM-12,-15
α10β1 Itga10
Itgb1
Col II/IV/VI/IX
α11β1 Itga11
Itgb1
Col I/IV/IX
αvβ1 Itgav
Itgb1
Fn; Vn; Opn
αvβ3 Itgav
Itgb3
Vn, Fn, Tn, Ln (α1
chain); Opn
Fg; tumstatin ADAM-15,
−23
αvβ5 Itgav
Itgb5
Vn; Opn TGFβ-LAP; endostatin
αvβ6 Itgav
Itgb6
Fn; Tn TGFβ-LAP
αvβ8 Itgav
Itgb8
Vn; Col IV; Fn; Ln
(α1 chain)
TGFβ-LAP
αIIbβ3 ItgaIIb
Itgb3
Fn; Vn Fg; vWF
αLβ2 Itgal
Itgb2
ICAM-1,2,3,5
αMβ2 Itgam
Itgb2
Fg; iC3b; FX ICAM-1;
VCAM-1
αXβ2 Itgax
Itgb2
Fg; iC3b
αDβ2 Itgad
Itgb2
ICAM-3;
VCAM-1
αEβ7 Itgae
Itgb7
E-cadherin
Abbreviations: ADAM, a disintegrin and metalloprotease; Col, collagen; Fg, ﬁbrinogen;
Fn, ﬁbronectin; FX; coagulation factor X; FXII, coagulation factor XIII; iC3b, inactivated
complement component C3b; ICAM, Intra-Cellular Adhesion Molecule; Ln, laminin;
MadCAM, mucosal addressin cell adhesion molecules; Nn, nephronectin; Opn,
osteopontin; pp-vWF, prepro-von Willebrand Factor; TGFβ-LAP, Transforming
Growing Factor β latency-associated peptide; Tn, tenascin; Tsp, thrombospondin;
tTG, tissue transglutaminase; VCAM, Vascular Cell Adhesion Molecule; Vn, vitronectin;
vWF, von Willebrand Factor.
Table based on: van der Flier and Sonnenberg, 2001; Barczyk et al., 2010; Durbeej, 2010,
with further details fromHuet al., 1995; VenstromandReichardt, 1995; Staniszewska et al.,
2008.
194 S. Thorsteinsdóttir et al. / Developmental Biology 354 (2011) 191–207along the axis of the embryo (Fig. 2). The paraxial mesoderm is organised
in segments, the somites (Fig. 2A), which are formed in a sequential
pattern all along the rostro-caudal axis (Kalcheim and Ben-Yair, 2005).
Soon after their formation, the somites separate into the ventral
sclerotome and the dorsal dermomyotome and subsequently some
dermomyotomal cells give rise to themyotome (Fig. 2B). The sclerotome
gives rise to the axial skeleton and the dermomyotome to all trunk, limb
and a few head muscles, as well as some dermal, endothelial, smooth
muscle and brown fat precursors (Buckingham, 2006; Kalcheim and
Ben-Yair, 2005; Scaal and Christ, 2004; Seale et al., 2008). Finally, a
population of cells (the so-called syndetome), located at the rostral and
caudal interface between sclerotome and myotome (Fig. 2B), gives rise
to the tendons linking muscles to the axial skeleton (Brent et al., 2003).
Although the division of the paraxial mesoderm into somites is not
necessary for the differentiation of its different derivatives, the
formation of segmentally organised epithelial somites is absolutely
essential for the proper organisation of these derivatives, particularly
the vertebral column (Burgess et al., 1996) and the hypaxial portion of
themyotome (Wilson-Rawls et al., 1999). Theﬁbronectinmatrix,which
normally surrounds the rostral presomitic mesoderm and early somites
(Figs. 2A, 3A) (Duband et al., 1987; Ostrovsky et al., 1983, 1988) plays a
crucial role in the process that converts the mesenchymal presomitic
mesoderm into epithelial somites (George et al., 1993; Martins et al.,
2009; Rifes et al., 2007). A ﬁbronectin matrix is also assembled in the
clefts between somites of the chick embryo (Martins et al., 2009; Rifes
et al., 2007) and has proven to be essential to stabilise these clefts in
zebraﬁsh embryos (Koshida et al., 2005).
Soon after somites form, a basement membrane matrix containing
laminin (Bajanca et al., 2004; Duband et al., 1987; Krotoski et al., 1986),
collagen IV (Duband and Thiery, 1987; Leivo et al., 1980), nidogen/
entactin (Zagris et al., 1993) and perlecan (Soulintzi and Zagris, 2007) is
progressively laid down around the somite (Fig. 2A). Laminin 111 is
probably the ﬁrst constituent of this basementmembrane since the gene
encoding the laminin α1 chain, Lama1, is already transcribed in the
presomitic mesoderm in the mouse (Anderson et al., 2009; Miner et al.,
2004). All these basementmembrane components remainpresent on the
dermomyotome (Fig. 2B) after the sclerotomal cells de-epithelialise and
disperse (Bajanca et al., 2004; Duband and Thiery, 1987; Krotoski et al.,
1986; Zagris et al., 2000) and ﬁbronectin remains closely associatedwith
this basement membrane (Cachaço et al., 2005; Ostrovsky et al., 1988).The dermomyotome as an epithelium of multipotent progenitors
The dermomyotome is a sheet-like epithelium with its basal side
facing the ectoderm and curving into lips towards the sclerotome at its
four sides (Figs. 2B, 3B,C). The dermomyotome is the precursor of all
myogenic cells of the body and limbs, which are generated in a
developmentally regulated and stepwise manner (Buckingham, 2006;
Kalcheim and Ben-Yair, 2005; Scaal and Christ, 2004). The capacity of
the dermomyotome to generate sucha remarkable number of precursor
cells must therefore depend on the tight regulation of mechanisms
Table 3
Integrin subunits expressed during mouse skeletal muscle development in vivo, their expression patterns in skeletal muscle and inactivation phenotypes. When the mouse expression
pattern is unknown or incomplete, the chick expression pattern is presented. Abbreviations used: MPC =myogenic precursor cell.
Subunit Expression pattern
in muscle
Knock-out References
α1 Mouse: myotome from E10.5; MPCs
migrating to limbs; muscle masses
at E11.5–E13.5
Viable and fertile; no phenotype
in skeletal muscle
Gardner et al., 1996;
Bajanca and Thorsteinsdóttir, 2002
Bajanca et al., 2004;
Cachaço et al., 2005.
α3 Chick: adult myoﬁbres Die neonatally; abnormal development
of kidneys, lung and skin; no phenotype
in skeletal muscle
Bao et al., 1993;
Kreidberg et al., 1996;
DiPersio et al., 1997.
α4 Mouse: dermomyotome at E9.5;
on differentiated myocytes epaxially,
on hypaxial lip and young myotomal
cells hypaxially; on both dermomyotome
lips after dissociation of central
dermyotome; E12.5 trunk and
E12.5–14.5 forelimb muscle masses;
primary and secondary myotubes;
absent on secondary myoblasts
Die at E11–14; defects in placenta and
heart; no skeletal muscle phenotype
in chimaeras
Rosen et al., 1992;
Yang et al., 1995;
Yang et al., 1996b;
Bajanca et al., 2004;
Cachaço et al., 2005.
α5 Mouse:epithelial somites;
differentiated myocytes in myotome;
MPCs migrating to limbs; trunk and
forelimb muscle masses at E12.5
Die at E10–11; defects in the posterior trunk,
including impaired somite formation;
chimaeras show muscle dystrophy
Yang et al., 1993;
Goh et al., 1997;
Taverna et al., 1998;
Bajanca and Thorsteinsdóttir, 2002;
Bajanca et al., 2004;
Cachaço et al., 2005.
α6 Mouse: dermomyotome and myotome;
E13.5–E14.5 trunk and limb muscles
Die neonatally; severe skin blisters, absence
of hemidesmosomes
Bronner-Fraser et al., 1992;
Chick: myotome; limb MPCs and
myoblasts; primary myotubes
Georges-Labouesse et al., 1996;
Bajanca et al., 2004;
Cachaço et al., 2005.
α7 Mouse: E10.5 myotome; E13.5
intercostal and pectoral muscles;
myotendinous junctions
50% lethality at midgestation; 50% viable and
fertile; progressive muscular dystrophy
Bao et al., 1993;
Velling et al., 1996;
Mayer et al., 1997;
Bajanca et al., 2004;
Cachaço et al., 2005.
α9 Mouse: E12.5 diaphragm and tongue,
E14.5 myotubes
Die neonatally with respiratory failure Wang et al., 1995;
Huang et al., 2000.
αv Mouse: E10.5 myotome; trunk and
forelimb muscle masses at E12.5;
E15.5 myotendinous junctions
80% lethality due to placental defects,
20% born with intracellebral haemorrhages
Hirsch et al., 1994;
Bader et al., 1998;
Schwander et al., 2003
Cachaço et al., 2005.
β1 Mouse: β1A present on all myogenic cells
(including all muscle ﬁbres) until E17.5,
when it is progressively replaced by β1D
β1-null lethal at preimplantation; β1D-null
viable; β1D knock-in lethal at midgestation
(placental failure) or neonatally
(reduced muscle mass); conditional β1-null
(skeletal α-actin Cre) lethal neonatally
(reduced muscle mass)
Fässler and Meyer, 1995;
van der Flier et al., 1995, 1997;
Zhidkova et al., 1995;
Belkin et al., 1996;
Baudoin et al., 1998;
Cachaço et al., 2003;
Schwander et al., 2003.
β3 Mouse: assumed to pair with αv at
myotendinous junctions in E14.5 in
conditional β1-null myotubes.
Viable and fertile; haemorrhage; placental
defect; no phenotype in muscle
Hodivala-Dilke et al., 1999;
Schwander et al., 2003
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promoting entry into the myogenic programme.
The dermomyotome epithelium grows progressively through
symmetric cell divisions and cell ﬂattening (Ben-Yair et al., 2003) and
is characterised by the expression of the transcription factors Pax3
(Fig. 3B) and Pax7 which mark uncommitted cells (Buckingham and
Relaix, 2007). Pax3 is required for the survival of cells in the hypaxial
dermomyotome (Bajard et al., 2006; Borycki et al., 1999a) and Pax3/
Pax7 expression is essential for the formation of all dermomyotome-
derived myogenic precursors except those of the primary myotome
(Relaix et al., 2005). Notch signalling has also been implicated inmaintaining theundifferentiated state of thedermomyotome(Hirsinger
et al., 2001).
Accumulating evidence also suggests that the epithelial state of the
dermomyotome contributes to its capacity to maintain its uncommitted,
proliferative state. The epithelial cells of the dermomyotome adhere to
each other through N-CAM and N-cadherin, the latter being enriched in
the apically localised adherens junctions (Duband et al., 1987) where it
forms a complex with its intracellular partners β-catenin, plakoglobin
(γ-catenin), p120 catenin and α-catenin (Meng and Takeichi, 2009).
These proteins form the link between cadherins and the cytoskeleton and
adherens junctions can function as a mechanosensor and signalling
Fig. 2. Embryonic skeletalmuscle development. A. Skeletalmuscle is derived fromsomiteswhichare epithelial balls of cells locatedonboth sides of theneural tube. They are surrounded by
a basement membrane and a ﬁbrillar ﬁbronectin matrix and also contain a loose ﬁbronectin-rich matrix in their centre, the somitocoel. B. As the somite differentiates, the ventral part of
each somite undergoes anepithelium-to-mesenchyme transition, giving rise to themesenchymal sclerotome and its interstitialmatrix. The dorsal part of the somite remains epithelial and
is called the dermomyotome. Subsequently, Myf5-positive cells enter the myotomal space from the epaxial, hypaxial, rostral and caudal lips of the dermomyotome and organise the
basement membrane that comes to separate the sclerotome from the myotome. These cells then migrate to the centre, where they start differentiating into elongated myocytes which
eventually span the width of the segment. C. The dermomyotome dissociates, giving rise to Pax3/Pax7-positive cells whilst (in the trunk) myotomal myocytes translocate, changing
orientation. Some Pax3/Pax7-positive cells differentiate into primary myoblasts which fuse with the preexisting myocytes, forming primary myotubes. As more and more primary
myoblasts fuse with these primary myotubes (red), they elongate, assemble a laminin 211-containing basement membrane, get innervated (motor end plates represented as groups of
black dots) and eventually attach to bone through tendons (grey) at their ends. Eventually, some Pax3/Pax7-positive cells, still present within the muscle masses, differentiate into
secondary myoblasts. Secondary myoblasts adhere to primary myotubes near the innervation site and fuse with each other forming secondary myotubes along the primary myotubes.
These progressively elongate, assemble their own basement membrane, get innervated and attach to tendons. Some Pax3/Pax7 cells remain within the muscle masses and give rise to
satellite cells. These satellite cells become quiescent and reside on the surface of myoﬁbres, under the basement membrane.
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Ingber, 2006). A ﬁbronectin matrix is essential to induce the apical
polarisation ofN-cadherin in cells of the rostral presomiticmesodermand
to maintain the N-cadherin-containing adherens junctions in chick
epithelial somites (Martins et al., 2009). Whether ﬁbronectin still plays
such a role at the dermomyotome stage or whether the laminin-
containing basement membrane (Fig. 3C) has taken over this function
has not yet been addressed. Adhesion through N-cadherin is essential
to maintain the epithelial integrity of the dermomyotome in the
quail as dermomyotomal cells electroporatedwith anN-cadherin lacking
the extracellular domain deepithelialise, lose their basal laminin matrix
and disperse into the subectodermal domain (Cinnamon et al., 2006).
Canonical Wnt signalling through Wnt6, expressed in the ectoderm
overlying the somites, is reported to be essential for the maintenance
of the epithelial state of the dermomyotome in the chick (Linker et al.,
2005), and canonical Wnt1 and Wnt3a signalling stimulates dermo-
myotome cell proliferation (Brauner et al., 2010; Galli et al., 2004).
However, the key effector of canonical Wnt signalling, β-catenin, is also
a major player in the maintenance of cadherin-based adhesions and
recent studies have shown that the interdependence between these two
pools of β-catenin is complex (Heuberger and Birchmeier, 2010). Thus it
will be interesting to dissect out further the interplay between the
adhesion and signalling functions of β-catenin in the maintenance of the
dermomyotome.
The interaction of dermomyotomal cells with their basement
membrane is also important for the maintenance of their undifferen-
tiated state. The dermomyotomal basement membrane is composed of
laminin 111 and 511 (Fig. 3C) as well as collagen type IV (Fig. 3D),
perlecan and nidogen (Anderson et al., 2009; Bajanca et al., 2006) and
the presence of the laminin receptor α6β1 integrin on the surface of
dermomyotomal cells (Fig. 3B) indicates they bind to their basement
membrane through this integrin (Bajanca et al., 2004). As described for
other systems (Fuchs, 2007), positional cues not only from the
N-cadherin-containing adherens junctions (Cinnamon et al., 2006; seeabove), but also from the basement membrane (Bajanca et al., 2006)
may play critical roles in promoting symmetric cell divisions and the
undifferentiated state of the dermomyotomal epithelium. In accordance
with this hypothesis, blocking the binding between α6β1 integrin and
laminin inducesprecociousmyogenesis in thedermomyotome(Bajanca
et al., 2006). Thus the experimental detachment of the dermomyotomal
cells from their basement membrane appears to push the balance of
signals promoting the undifferentiated state towards one that promotes
differentiation. This indicates that for the epithelial cells of the
dermomyotome, loss of contact to their basement membrane is one of
the cues that drive their differentiation (also see The initiation of epaxial
myotome formation section).
Bmp4, expressed in thedorsal neural tube and lateralmesoderm,has
also been implicated as a repressor of precocious myogenesis in the
dermomyotome (Hirsinger et al., 1997; Linker et al., 2003; Patterson
et al., 2010; Reshef et al., 1998). Interestingly, during pancreatic
development, Bmp-4 and −6 signalling and laminin 111-induced
signalling through α6β1 and dystroglycan synergise to maintain the
proliferative and undifferentiated state of pancreatic β-cell precursors
(Jiang and Harrison, 2005). Whether a similar collaboration between
Bmps and laminin occurs in the dermomyotome is not known,
but studies in zebraﬁsh indicate that extrinsic factors other than
Bmps contribute in a decisive way towards maintaining the non-
differentiated state of cells in the dermomyotome (Patterson et al.,
2010). Altogether, these observations suggest that the epithelial state,
including its characteristic pattern of cell–cell and cell–ECM engage-
ment, collaborates and/or interacts with pathways activated by Notch,
Wnts and Bmps, in order to repress precocious myogenesis in the
dermomyotome.
The initiation of epaxial myotome formation
The ﬁrst cells of the myotome originate from the epaxial lip of the
dermomyotome (Fig. 3B,F; termed dorso-medial lip in avians) and give
Fig. 3. Potential relationships betweenmyogenic cells and the ECM. A. Longitudinal section of the tail of an E11.5mouse embryo labelled forﬁbronectin. Aﬁbronectinmatrix surrounds the
presomiticmesoderm (PSM) and epithelial somites and some immunoreactivity is also found in the somitocoel. The forming somite is termed S0, themost recently formed somite is SI and
so forth. B. Transverse section of a caudal somite of an E11.5 mouse embryo labelled for integrinα6 (green) which is present in themyotome, dermomyotome, neural tube, blood vessels,
notochordandectoderm. Pax3(red)marks the cells of thedermomyotomeand thedorsal neural tube. Stainingofblood cells isnon-speciﬁc. C. Longitudinal sectionof theepaxial regionof a
dermomyotome/myotomeof an E10.0mouse embryo showing three distinct laminin (green)-containingbasementmembranes: the one lining thedermomyome basally (yellowarrows),
the one separating the myogenin-positive (red) myotome from the sclerotome (red arrows) and the one lining the ectoderm (white arrows). D–E. Transverse sections showing
delamination and initial migration of Pax3-positive (red) forelimb MPCs in an E10.0 mouse embryo. D. Collagen IV (green) lines the dermomyotome (white arrows), somatopleura,
ectoderm, endoderm and blood vessels; note discontinuous staining at hypaxial lip (yellow arrow). E. A ﬁbrillar ﬁbronectin matrix (green) ﬁlls themesenchymal space andMPCs invade
thismatrix duringdelamination (yellowarrow)andmigration. F–G. Sagittal confocal sectionsof rat embryos at thorax level. F. E12.5 rat embryo. Segmentedepaxialmyotomes are forming
withmyocytes (red), parallel to the axis; segments are separatedbya thick ECM(green). G. E15.5 rat embryo. Epaxialmyocytes (red)have changed their orientation and length to form the
complex epaxial muscle masses and the ECM (green) has been re-organised. PSM= presomitic mesoderm; DM= dermomyotome; MHC=myosin heavy chain; V= vertebra; DRG=
dorsal root ganglia; TS= transverso-spinalismuscles; LM= longissimusmuscle; IC= iliocostalismuscle. Scale bar: 50 μm(C); 100 μm(A, B, D, E, F); 250 μm(G). Formethods see Bajanca
et al. (2006) and Deries et al. (2010).
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Kahane et al., 1998; Patapoutian et al., 1995; Venters et al., 1999).
Myogenesis is induced through the activation of themyogenic regulatory
factors (MRFs) which commit cells to themyogenic lineage (Myf5, Mrf4,
and MyoD) and then activate their differentiation programme (myo-
genin, MyoD, and Mrf4) (Buckingham, 2006). Wnt and Shh signalling
have been shown to induce the expression of Myf5 in the epaxial lip,
which is then followed by the translocation of the expressing cells to theunderlyingmyotome and their subsequent differentiation into elongated
myocytes (Bothe et al., 2007; Buckingham, 2006). Although low levels of
Myf5 expression are already present in the rostral presomitic mesoderm
and epithelial somites (Linker et al., 2003), sustained epaxial Myf5
expression requires Wnt1 (and/or Wnt3a) from the dorsal neural tube,
Shh from the notochord/ﬂoorplate and inhibition of Bmp signalling
through noggin expression (Amthor et al., 1999; Borycki et al., 1999b;
Hirsinger et al., 1997; Münsterberg and Lassar, 1995). In the mouse,
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Gli3 to promote Myf5 expression (Borello et al., 2006; McDermott et al.,
2005) and, in birds, Shh signalling has been shown to potentiate Wnt1
signallingby inducingQSulf1, a geneencoding anextracellular sulphatase
which releases heparan sulphate-bound Wnt1 leading to MyoD
activation (Dhoot et al., 2001). Interestingly, in zebraﬁsh, a laminin-
dependent deposition of heparan sulphate proteoglycans protects the
centralmyotome fromBmp signals (Dolez et al., 2011) butwhether such
a mechanism restricts Bmp signalling during epaxial myogenesis in
higher vertebrates has not been addressed.
Recent evidence in chick suggests that the translocation of the
differentiating cells at the epaxial lip is preceded by an asymmetric cell
division, as measured by spindle orientation and the asymmetric
distribution of Numb (Holowacz et al., 2006; Venters andOrdahl, 2005).
As a consequence, one daughter cell enters the myotome, whilst the
other continues to reside in the dermomyotome epithelium. Numb is an
inhibitor of Notch-signalling (McGill and McGlade, 2003). It was logical
to suggest that its presence in the epaxial lip might inhibit Notch
signalling, permitting the activation of MRFs and the initiation of
myogenic differentiation (Venters and Ordahl, 2005; Holowacz et al.,
2006). However, no effect on Notch signalling was observed when
Numb was overexpressed under the control of the Myf5 Early Epaxial
Enhancer in the mouse (Jory et al., 2009). Rather, overexpression of
Numb favoured symmetric over asymmetric cell divisions, resulting in
more dermomyotomal precursors and consequently more dermal and
myogenic cells (Jory et al., 2009). It is becoming increasingly clear that
Numb has many functions which are unrelated to Notch (Gulino et al.,
2010). One of these involves the endo- and exocytosis of cadherins,
contributing to the renovation of adherens junctions (Rasin et al., 2007;
Wang et al., 2009); another is the recycling of integrins, contributing to
cellmigration (Nishimura andKaibuchi, 2007).WhetherNumbdisplays
those functions in thedermomyotome remains to be seen.Nevertheless,
the observation that Numb immunoreactivity is enriched on the basal
side of dermomyotomal cells (Holowacz et al., 2006; Venters and
Ordahl, 2005) raises the interestingpossibility that itmay be involved in
modulating adhesion to the basementmembrane by endocytosis of the
α6β1 integrin. If Numb plays such a role at the epaxial lip it could
weaken the attachment of cells to the basementmembrane, before they
enter mitosis, thus promoting asymmetric cell division. In support of
this hypothesis, delaminating epaxial lip cells in the Myf5nlacZ/nlacZ
mutant do not haveα6β1 integrin on their surface (Bajanca et al., 2006).
This demonstrates that there is amechanismto remove this integrin and
that cell surface expression is only restored in the myogenic daughter
cell when Myf5 is active. The question of what induces the increased
frequency of asymmetric cell divisions at the epaxial lip remains. As
mentioned above, Wnt and Shh signalling have been shown to induce
the expression of Myf5, but whether they also promote pathways
leading to an asymmetric cell division, has not been addressed.
Formation and role of the myotomal basement membrane
The myotomal basement membrane separates the forming myo-
tome from the sclerotome (Figs. 2B, 3C) and starts being assembled soon
after theﬁrstMyf5-expressing cells enter themyotomal area (Anderson
et al., 2007; Bajanca et al., 2006; Tosney et al., 1994). It is important to
note that the myotomal basement membrane is distinct from the
basement membrane of the dermomyotome (Tosney et al., 1994) and
that it is also different from the laminin-211-containing basement
membrane that surroundsdifferentiatedmuscle cells (Fig. 2C),which, in
the case of the mouse, only becomes clearly detectable in the E11.5
myotome (Cachaço et al., 2005).
Amajor function of themyotomal basementmembrane is to create a
barrier between the myotome and the sclerotome and promote the
spatial restriction of myotomal cells within the myotomal area. When
there is a defect in thedepositionof themyotomalbasementmembrane,
myotomal cells tend to spread medially. The absence of a continuousbasementmembrane and, consequently,medial spreading ofmyotomal
cells or their precursors is observed in embryos lacking Myf5/Mrf4
(Myf5nlacZ/nlacZ; Tajbakhsh et al., 1996), Shh and Gli2/3 (Anderson et al.,
2009), Paraxis (Wilson-Rawls et al., 1999) and Dmrt2 (Seo et al., 2006),
suggesting that the products of these genes play a direct or indirect role
in the organisation of this basement membrane.
Unlike ﬁbronectin matrix assembly, cell surface receptors are not
required for laminin assembly, since laminin molecules bind to each
other through their short arms (Fig. 1) even in the absence of cells
(Colognato and Yurchenco, 2000; LeBleu et al., 2007; Yurchenco et al.,
2004). However, cell–laminin interactions are necessary to place
basement membranes in close contact with cells, where they are
physiologically relevant, and serve as nucleating points for laminin
assembly (Colognato and Yurchenco, 2000; LeBleu et al., 2007;
Thorsteinsdóttir, 1992). Thus cells do not drive, but they organise
laminin assembly. Both dystroglycan and β1-integrins have been
implicated in organising a laminin matrix but exactly what role each
plays is a matter of debate. Although some studies suggest that
dystroglycan is required to bind laminin on the cell surface and β1-
integrins are necessary for de novo laminin organisation (Henry et al.,
2001; Lohikangaset al., 2001; Raghavanet al., 2000), bothDag1-null and
Itgb1-null embryonic stem cell-derived embryoid bodies assemble a
laminin matrix (Li et al., 2002). On the other hand, Itgb1-null embryos
are developmentally retarded by E4.5 and form no true basement
membranes (Fässler andMeyer, 1995; Stephens et al., 1995) and Dag1-
null embryos are morphologically abnormal from E6.5 onwards with
disrupted laminin organisation in Reichert's membrane (Williamson
et al., 1997). This indicates an essential role for both receptors in the
formation of at least a subset of basement membranes.
As far as we know, α6β1 (Fig. 3B) is the only laminin-binding β1
integrin expressed by the early epaxial myogenic precursors (Bajanca
et al., 2004) and these cells also express dystroglycan (Anderson et al.,
2007). Epaxial MPCs in Myf5nlacZ/nlacZ embryos do not retain the α6β1
integrin on their cell surface as they enter the myotome (Bajanca et al.,
2006). Thus,Myf5 expression is essential to maintain theα6β1 integrin
on early epaxial myogenic cells. Furthermore, although laminin and
other basement membrane molecules are detected in the myotomal
area of Myf5nlacZ/nlacZ embryos, they do not organise into a continuous
matrix (Bajanca et al., 2006). Consequently, the myogenic cells spread
medially (Bajanca et al., 2006; Tajbakhsh et al., 1996). Myf5 therefore
appears to play an essential, but indirect, role in myotomal basement
membrane assembly by maintaining the α6β1 integrin on the cell
surface. This integrin then mediates the organisation of the myotomal
basementmembrane into a barrier, retaining cells within themyotomal
compartment (Bajanca et al., 2006). Whether dystroglycan is also
required for the assembly of this basement membrane is currently not
known.
Sonic hedgehog signalling is also essential for the assembly of the
myotomal basement membrane. The expression of Lama1 in epithelial
somites and sclerotome depends on Shh signalling and when laminin
111 is absent, the basement membrane does not form, even though
laminin 511 is present and MPCs express both dystroglycan and the
α6β1 integrin (Anderson et al., 2009). Thus, as previously observed for
Reichert'smembrane (Miner et al., 2004), laminin 511 cannot substitute
for laminin 111 in the formation of the myotomal basementmembrane
(Anderson et al., 2009). This is in contrast to its ability to partially
compensate for the absence of laminin 111 in the basement membrane
of the embryonic ectoderm/epiblast (Miner et al., 2004). It will be
interesting to see inwhatway these situationsdiffer, to understandwhy
laminin 511 sometimes compensates for the absenceof laminin 111 and
sometimes not.
Paraxis (Wilson-Rawls et al., 1999) and Dmrt2 (Seo et al., 2006)
mutant embryos show a similar phenotype in the myotome, in that
myotomal cells spread medially and elongated myocytes are disorga-
nised and misaligned. In Paraxis-null embryos, mRNA expression for
laminin was detected but protein distribution showed a disrupted
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laminin isoform was present (laminin 111, laminin 511 or both). In
Dmrt2-null embryos, theα1 chain of laminin 111wasundetectable both
in the dermomyotome and in the myotome (Seo et al., 2006).
When cells enter the myotome they normally differentiate and
organise into a parallel array of elongated myocytes (Fig. 2B). When
laminin-α6β1 binding is blocked in explant cultures of wild-type
embryos, the normal parallel alignment of elongating and elongated
myocytes is disturbed, suggesting thatα6β1mediates theattachmentof
themyocyte tips to themyotomal lamininmatrix (Bajanca et al., 2006).
Both Paraxis- and Dmrt2-null embryos show severe defects in myocyte
organisation and elongation (Wilson-Rawls et al., 1999; Seo et al., 2006),
which is likely due to the absence of a normal myotomal basement
membrane in both mutants. It remains to be seen whether Paraxis and
Dmrt2 regulate the deposition of this basement membrane by
controlling the production of laminin 111 (as in the case of Shh
signalling) or whether they act through laminin receptors required for
its assembly (as Myf5). The recent observation that Dmrt2 regulates
Myf5 expression raises the possibility that Dmrt2 affects laminin
assembly in two ways: through laminin 111 production and by
regulating Myf5 and thus maintaining α6β1 integrin on myotomal
cells (Sato et al., 2010). In accordancewith this, overexpression ofDmrt2
in the somite leads to enhanced laminin assembly near myotomal cells
(Sato et al., 2010). Finally, in the chick embryo, Wnt11 and the PCP
pathway have been shown to play crucial roles in the orientation of
myotomal myocytes (Gros et al., 2009) but whether they do so directly
or through inﬂuencing the organisation of the myotomal basement
membrane has not been addressed.
After the initial stages of epaxial myotome formation, the
myotome enters a new phase where it extends both in length (in
the epaxial-hypaxial direction) and in width (in the medio-lateral
direction). This growth is achieved by the entry of cells derived from
all four dermomyotome lips (Buckingham, 2006; Kalcheim and Ben-
Yair, 2005). The epaxial myotome grows in the dorsal direction by
the addition of new cells from the growing epaxial dermomyotomal
lip. At this stage, cells entering into the epaxial myotome are
dependent on both Myf5 and Mrf4 expression to proceed with their
myogenic programme (Kassar-Duchossoy et al., 2004). These cells
express α6β1 on their surface and probably contribute to the growth
of the myotomal basement membrane in a dorso-medial direction,
since blocking α6β1-laminin binding in E9.5 embryo explants leads
to discontinuities in the laminin matrix at the epaxial lip (Bajanca
et al., 2006).
Themyotome also grows in width by addition of cells coming from
the rostral and caudal lips of the dermomyotome (Gros et al., 2004;
Venters et al., 1999). These cells enter the myotome medially,
between the pre-existing myocytes and the myotomal basement
membrane (Fig. 2B), and the myotomal basement membrane
probably acts as a substrate for cell migration mediated by α6β1
(Bajanca et al., 2006) and/or dystroglycan (Anderson et al., 2007).
Interestingly, unlike α6β1, dystroglycan is enriched at the side where
cells are in direct contact with the myotomal laminin matrix
(Anderson et al., 2007), suggesting a different role from that of
α6β1. Cells from rostral and caudal lips migrate in a caudal and rostral
direction, respectively, until they reach midway between those lips
(Fig. 2B). There they upregulate myogenin and start elongating,
resulting in the characteristic V-shape of the myotome in the latero-
medial direction (Venters et al., 1999). The tip of the V is an area
where laminin immunostaining is discontinuous (Fig. 2B), indicating
that laminin is being assembled there to account for the medial
growth of the myotome (Bajanca et al., 2006). Furthermore, since
myocyte elongation is dependent on contact between the myocyte
tips and the laminin-containing myotomal basement membrane
(Bajanca et al., 2006), one can hypothesise that elongation of the
myotomal myocytes is facilitated by the rostro-caudal displacement
of the basement membrane (Fig. 2B).As the myocytes elongate, they also start expressing the α4β1 and
α5β1 integrins and when they reach full length, their rostral and
caudal ends cross the dermomyotome epithelium and appear to
attach to the ﬁbronectin-rich extracellular matrix present between
segments (Fig. 2B) (Bajanca et al., 2004). It is thus plausible thatα4β1
and/or α5β1 integrins and ﬁbronectin play a role in reinforcing
myocyte–ECM interactions at those intersegmental sites. Support for
this hypothesis comes from studies in zebraﬁsh, where knock-down
of the two ﬁbronectin genes (fn1+ fn3) results in a perturbation of
myotome boundaries which leads to disorganised slowmyoﬁbres and
formation of abnormally long fast myoﬁbres (Snow et al., 2008).
Finally, in themouse embryoMyoD expression comes up relatively
late, thus marking a different population than in the chick, where it is
expressed at the onset of myogenesis in the somite (Buckingham
et al., 1992). MyoD is ﬁrst detected epaxially at around E10.5 and
MyoD-positive elongated myocytes upregulate the laminin receptor
α7β1, and, concomitantly, α6β1 expression in the myotome becomes
considerable weaker (Bajanca et al., 2004). This coincides with the
deposition of laminin 211 within the myotome (Cachaço et al., 2005)
and thus indicates a shift in the adhesion of myocytes to the basement
membrane separating the myotome from the sclerotome, to the
adhesion to a pericellular laminin 211 matrix.
Early steps of hypaxial myogenesis
Hypaxial myogenesis involves two developmental programmes or
a combination of these two programmes. The ﬁrst one involves the
ventral translocation of the hypaxial dermomyotomal lip and the
hypaxial myotome into the somatopleure, giving rise to the
prevertebral, intercostal and abdominal muscles, whereas the second
programme involves the delamination of myogenic precursor cells
(MPCs) from the hypaxial dermomyotome and their long-range
migration to their target sites, giving rise to the muscles of the limbs,
diaphragm and tongue (Bothe et al., 2007; Evans et al., 2006).
Interestingly, certain muscle groups have adopted a combination of
these two ways for translocation, as in the case of perineal muscles,
where non-differentiated precursors migrate from the lateral dermo-
myotome into the hindlimb, upregulate MyoD and then translocate
back into the trunk, towards the cloaca, where they adopt their ﬁnal
organisation (Evans et al., 2006; Valasek et al., 2005). Very little is
known about what cell–ECM interactions occur during these
developmental programmes.
The hypaxial myotome arises from the ventro-lateral aspect of the
dermomyotome (Christ et al., 1983; Cinnamon et al., 1999; Denetclaw
and Ordahl, 2000; Gros et al., 2004; Huang and Christ, 2000). The
signalling pathways that induce hypaxial myotome formation are
different from the ones seen epaxially in that Wnt7a from ectoderm
signals non-canonically through PKC, leading to increased transcrip-
tional activity of Pax3, and thereby activation of MyoD (Brunelli et al.,
2007). As the hypaxial lip of the dermomyotome extends into the
somatopleure it initially maintains its epithelial character and high
levels of proliferation, suggesting that it is continuously providing
new cells to the growing hypaxial myotome (Christ et al., 1983).
Paraxis has been shown to contribute towards themaintenance of this
epithelial and proliferative state of the hypaxial dermomyotome
(Wilson-Rawls et al., 1999) and elevated Pax3 expression promotes
its survival (Borycki et al., 1999a). However, as the ventro-lateral
extension progresses, the hypaxial lip eventually dissociates giving
rise to the muscle precursors of the abdominal musculature (Christ
et al., 1983).
During early stages of hypaxial myotome development, laminin
immunoreactivity is weaker and less continuous in the hypaxial
myotome when compared to its epaxial counterpart (Bajanca et al.,
2004; Cachaço et al., 2005) and the α6β1 integrin is only weakly
expressed in the hypaxial lineage (Bajanca et al., 2004). In contrast,
the ﬁbronectin and VCAM1 receptor, α4β1 integrin is strongly
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by early muscle precursors entering the hypaxial myotome (Bajanca
et al., 2004). This is different from the situation epaxially where α4β1
is only present on differentiated myocytes (Bajanca et al., 2004) and
suggests a difference in the cellular adhesion properties employed in
early differentiation of the epaxial versus hypaxial lineage (Bajanca et
al., 2004). It also suggests that α4β1-ﬁbronectin (and/or α4β1-
VCAM1) interactions may play a role in the ventral expansion of the
hypaxial dermomyotome and myotome. This hypothesis is supported
by the observation that implantation of hybridoma cells expressing an
anti-β1 integrin antibody in the chick embryo disturbs the ventral
growth of the hypaxial myotome (Jaffredo et al., 1988).
As mentioned above, at certain axial levels the hypaxial dermomyo-
tomal lip gives rise to MPCs that migrate away from the dermomyo-
tome, forming muscles (e.g. limb muscles, diaphragm, and tongue) at
distant sites (Buckingham et al., 2003; Christ and Brand-Saberi, 2002;
Francis-West et al., 2003). This event occurs earlier than the
development of the hypaxial myotome described above. A key step in
inducing delamination and migration at these levels is activation of the
tyrosine kinase receptor Met (c-met) in the hypaxial dermomyotomal
lip (Bladt et al., 1995;Heymannet al., 1996). c-met expression is induced
hypaxially by Pax3 in all somites (Epstein et al., 1996; Relaix et al., 2003;
Yang et al., 1996a), but Met signalling is only activated at the levels
where migrating MPCs normally arise because the Met ligand, scatter
factor/hepatocyte growth factor (SF/HGF), is secreted by the mesen-
chyme at those axial levels (Bladt et al., 1995; Brand-Saberi et al., 1996a;
Dietrich et al., 1999; Heymann et al., 1996). Thus it is believed that Met
signalling in response to SF/HGF engagement causes the epithelium-to-
mesenchyme transition and subsequent migration. The effects of HGF/
Met signalling in epithelial carcinomas are well known. Here, Met
signalling generally downregulates E-cadherin expression either di-
rectly or indirectly (e.g. through Snail activation) leading to the
dissociation of adherens junctions followed by induction of the
expression of matrix metalloproteases (MMPs), such as MMP-2 and
MMP-9, which degrade collagen type IV of basement membranes
(Desiderio, 2007). Met signalling also activates focal adhesion kinase
(FAK) which leads to changes in integrin function and modiﬁcations of
the cytoskeleton, compatible with the migration phenotype (Desiderio,
2007). Although very little is known about how Met signalling affects
these processes during delamination from the hypaxial dermomyo-
tome, expression of Itga6mRNA, encoding theα6 integrin subunit of the
α6β1 laminin receptor, is downregulated in limb level dermomyotomes
precisely when MPCs are delaminating (Bajanca and Thorsteinsdóttir,
2002). Furthermore, as Pax3-positiveMPCs exit andmigrate away from
the hypaxial lip, laminin and collagen IV lining the basal side of the
hypaxial dermomyotome is discontinuous (Fig. 3D), indicating that not
only are cells detaching from the basementmembrane but thismatrix is
also being degraded. Interestingly, experimentally increasing Pax3
expression, as observed in Pax3PAX3-FKHR-IRESnLacZ/+ embryos, results in
increased Met activation in all somites, leading to ectopic disruption of
the laminin-containing basement membrane of the hypaxial dermo-
myotome and cell delamination in thoracic somites (Relaix et al., 2006).
Thus together these observations point to a link betweenMet signalling
and basement membrane disengagement and degradation, leading to
MPC delamination and cell motility.
Very little is known about which cell–ECM interactions are
involved in MPC migration to the limbs and other distant sites. The
homeobox transcription factor Lbx1 is required for migration of MPCs
into the hindlimb and regions of the forelimb, whilst playing a less
important role in the movement of the MPCs of the hypoglossal chord
and the diaphragm (Brohmann et al., 2000; Gross et al., 2000; Schäfer
and Braun, 1999). Lbx1-positive MPCs express the cytokine receptor
CXCR4 during their migration, responding chemotactically to the
ligand stromal-derived factor 1 (SDF1) secreted by the mesenchyme
(Vasyutina et al., 2005). CXCR4-signalling plays a crucial role in the
directional migration of several embryonic cell populations (Raz andMahabaleshwar, 2009). For example, CXCR4 signalling stabilises cell
protusions on ﬁbronectin in migrating neural crest cells from Xenopus
laevis embryos (Theveneau et al., 2010). SDF-1/CXCR4 signalling has
also been shown to promote cell anchorage to the ECM (Raz and
Mahabaleshwar, 2009). In fact, high SDF-1 concentrations induce a
CXCR4-dependent attachment of zebraﬁsh endodermal cells to
ﬁbronectin through α5β1 and/or αvβ1 integrins (Nair and Schilling,
2008). CXCR4 signalling has been extensively studied in the
hematopoietic system and in carcinomas where it is reported to
increase expression of α4, α5, β1 and β3 integrin subunits, as well as
FAK activity, which indicates it may act by modulating ﬁbronectin
receptors (Jones et al., 2007; Sanz-Rodríguez et al., 2001). Thus CXCR4
signalling promotes cell–ECM attachment in a variety of ways and it is
tempting to suggest that it may control cell–ECM interactions during
the migration of MPCs to the limb bud and possibly also their
anchorage to the ECM when they reach their target sites. Migrating
limb MPCs express Itga5 and Itga1 mRNA, whereas no signal is
detected for Itga4, Itga6 and Itgav (Bajanca and Thorsteinsdóttir,
2002). However, as mentioned earlier, integrins are stable proteins
and thus the absence of mRNA signal does not necessarily mean the
absence of protein. Nevertheless, based on these mRNA expression
data, it seems likely that migrating MPCs are in a position to bind
ﬁbronectin (via α5β1) and collagens I, IV and IX, laminin 111 and 211
(via α1β1). A ﬁbronectin matrix is present in the whole mesenchyme
from the earliest stages of limb development (Fig. 3D) (Cachaço et al.,
2005; Kosher et al., 1982), collagen IV and laminin line the ectoderm
and blood vessels growing into the limbs (Fig. 3D) (Cachaço et al.,
2005; Godfrey and Gradall, 1998), whereas collagens I and IX only
appear later in tendon and cartilage development (Birk et al., 1997;
Ros et al., 1995; Savontaus et al., 1998). Injection of an antibody
against the cell-binding domain of ﬁbronectin blocks MPC migration
into the limb bud in the chick (Brand-Saberi et al., 1993) providing
direct functional evidence for a role for α5β1-ﬁbronectin engagement
in MPC migration. Limb MPC migration is, however, not affected in
chimeric mouse embryos containing wild-type and Itgb1-null (Fässler
and Meyer, 1995) or Itga5-null (Taverna et al., 1998) cells. However,
since MPCs adhere to each other and to the limb mesenchyme
through N-cadherin (Brand-Saberi et al., 1996b), it is possible that
Itgb1- and Itga5-null MPCs are carried to the limbs by adhering to
migrating wild-type cells (Fässler et al., 1996). Hyaluronan has also
been implicated in promoting MPC migration into the limb bud
(Krenn et al., 1991). Whether this is by providing a substrate for cells,
harbouring factors stimulating cell migration and/or whether it acts
by creating hydrated spaces through which cells can migrate (Spicer
and Tien, 2004) remains to be determined. In agreement with the
studies in chick, regeneration of amputated axolotl limbs involves
downregulation of collagen type I and laminin in the blastema whilst
ﬁbronectin, hyaluronan and tenascin-C are upregulated and form a
transition matrix which promotes the migration of myoblasts into the
regenerating area (Calve et al., 2010). Whether tenascin-C inﬂuences
MPC migration during limb development has not yet been addressed,
but seems unlikely since it is not expressed early enough (Kardon,
1998). However, it is expressed by early tendon precursors (Kardon,
1998; Ros et al., 1995) and may inﬂuence muscle formation later on
(see The translocation of the myotome section).
Dissociation of the dermomyotome
The epithelial structure of the dermomyotome is maintained as the
different waves of myotomal cells and/or hypaxial migrating MPCs are
generated from the four lips (see above). Eventually, however, the
dermomyotomal epithelium dissociates through an epithelium-to-
mesenchyme transition associated with an asymmetric cell division,
giving rise to dermal and myogenic precursors (Ben-Yair and Kalcheim,
2005; Cinnamon et al., 2006) as well as progenitors of endothelia and
smooth muscle (Buckingham, 2006; Kalcheim and Ben-Yair, 2005; Scaal
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dermomyotome at E10.5 in the mouse and around HH18 in the chick/
quail, and progressively spreads from the central domain towards the
epaxial and hypaxial lips (Ben-Yair andKalcheim, 2005; Gros et al., 2005;
Kassar-Duchossoy et al., 2005; Relaix et al., 2005). These lips then stay
epithelial for some time before they eventually disintegrate (Tajbakhsh
and Buckingham, 2000; Venters and Ordahl, 2002). In the chick,
disintegration of the dermomyotome occurs shortly after the down-
regulation of Wnt6 in the overlying ectoderm and the loss of Paraxis
expression in the dermomyotome (Geetha-Loganathan et al., 2006;
Linker et al., 2005; Marcelle et al., 2002; Rodríguez-Niedenführ et al.,
2003). Furthermore, recent evidence, also from the chick embryo, points
to a role ofmyotomal Fgfs in signalling to the dermomyotomepromoting
MAPK/ERK signalling and the upregulation of Snail1 (Delﬁni et al., 2009).
The Snail genes are well known regulators of cell–cell and cell–ECM
adhesion and act by promoting the endocytosis and transcriptional
repression of E-cadherin (Baumet al., 2008; Guarino et al., 2007;Wu and
Zhou, 2010), the adherens junction component of epiblast and epithelia
of ectodermal and endodermal origin. However, N-cadherin, rather than
E-cadherin, is the component of the dermomyotomal adherens junctions
(Duband et al., 1987; Marcelle et al., 2002) and N-cadherin remains
expressed on the cells that colonise themyotome (Cinnamonet al., 2006;
Delﬁni et al., 2009). It is thus unclear exactly how Snail1 acts in the
dermomyotome. One possibility is that it alone, or in synergy with Fgf
signalling, promotes the internalisation of the N-cadherin of adherens
junctions, but that this N-cadherin is then rapidly reinserted into the
membrane in the daughter cells that colonise the myotome.
Dermomyotome dissociation not only involves changes in cell–cell
adhesion, it also coincides with a downregulation of Itga6 mRNA in
the central dermomyotome (Bajanca and Thorsteinsdóttir, 2002), the
expression of the matrix metalloprotease MMP2 which cleaves
collagen IV (Duong and Erickson, 2004) and the disappearance of
the dermomyotomal basement membrane. Whether there is any
connection between the inducers of dermomyotome dissociation
discussed above (downregulation ofWnt6, Fgf signalling or upregula-
tion of Snail1) and the observed downregulation of Itga6 or the
activation of MMP2 has not been addressed. However, Fgf signalling
and Snail proteins have been reported to disrupt cell-basement
membrane engagement, activate MMP genes and promote cell
migration in other systems (Baum et al., 2008; Guarino et al., 2007;
Wu and Zhou, 2010).
As mentioned above, the loss of the epithelial morphology of the
dermomyotome is accompanied by an asymmetric cell division (Ben-
Yair and Kalcheim, 2005). In the quail embryo, the apical daughter cells,
which enter the myotome as muscle precursors (or give rise to
endothelial or smooth muscle cells) retain the apical N-cadherin-rich
domain, Pax3/Pax7 expression and express the Fgf receptor FREK
(Cinnamon et al., 2006). The myotomal cells have N-cadherin on their
cell surface (Inuzuka et al., 1991), so it is reasonable to propose that the
Pax3/Pax7-positive precursors entering the myotome adhere to the
myotomal cells through homophilic N-cadherin binding, ensuring they
remain within the muscle masses (Deries et al., 2010). Fgfs secreted by
the myotome may also engage the FREK receptor (Kahane et al., 2001)
and stimulate the proliferation of the Pax3/Pax7 positive cells. Pax3/Pax7
double mutants have a severe muscle deﬁcit (Relaix et al., 2005)
suggesting that sustained Pax3/Pax7 expression is essential for the self-
renewal aswell as the survival of this latepopulationof dermomyotome-
derived cells. The basal daughter cells of the asymmetric cell division, on
the other hand, do not retain signiﬁcant amounts of N-cadherin,
downregulate Pax3/Pax7, but retain theexpressionof the homeodomain
transcription factor Alx4 (Ben-Yair and Kalcheim, 2005; Cinnamon et al.,
2006), whichmarks their dermal fate (Cheng et al., 2004). Furthermore,
since basement membrane degradation exposes the dermomyotomal
cells to the adjacent interstitialmatrix, these basal daughter cells are in a
position to engage this matrix through integrins, promoting their
migration into the dermis.As mentioned above, the epaxial and hypaxial dermomyotomal
lips persist in an epithelial state much longer than the central
dermomyotomal sheet (Tajbakhsh and Buckingham, 2000; Venters
and Ordahl, 2002) and, interestingly, at E11.5 both of these epithelial
tissues express mRNA for the α4 integrin subunit (Bajanca et al.,
2004). Whether this integrin promotes their epithelial state or
whether it acts later when the lips eventually de-epithelialise,
remains to be determined. Very few studies have addressed the
mechanism behind the persistence of these epithelia, but in the chick
embryo, Wnt11 in the epaxial lip and ectodermal Wnt6 near the
hypaxial lip have been implicated in promoting their epithelial state
(Geetha-Loganathan et al., 2006).
The translocation of the myotome
After the dissociation of the dermomyotome sheet, the myotome
enters a new phase of development. Each myotome, by deﬁnition,
spans only a single somite segment and is initially composed of
mononucleate cells (Fig. 3F). Cell fusion occurs at the later stages of
myotome development (Fig. 2C) and binucleate cells and multinu-
cleate myotubes are found within the mouse myotome at E11.5
(Ontell et al., 1995; Venters et al., 1999). Soon after, the segmented
structure of the myotomes disappears, and they contribute to the
early muscle masses of the multi-segmental muscles (Figs. 2C, 3G).
This reorganisation event is comparatively sudden, occurring within
36 h in the epaxial region of the mouse (from E11.5 until E13.0),
raising the question of how this transformation is achieved in such a
short period of time.
It has recently been demonstrated that the mononucleated epaxial
myotomal myocytes do not undergo apoptosis but rather participate
in the formation of the axial deep back muscles (Deries et al., 2010).
As the myocytes becomemultinucleated and elongate, they undergo a
change of orientation (Fig. 2C). The dorsal-most myocytes start to tilt
at their rostral tip. This tilting has two consequences, ﬁrst the
myocytes are no longer parallel to the embryonic axis, and second, a
cleavage plane is created that separates the dorsal myocytes from the
rest of the myotome. Later on, more cleavage planes are formed and
the myocytes of the four new epaxial muscle masses are no longer
parallel to the axis (Fig. 3G) (Deries et al., 2010). The morphogenesis
of the epaxial muscles raises the question of the force that drives the
myotome to change into the complex axial muscles.
Progenitors of the connective tissue of muscles and of tendons
expressing the transcription factor scleraxis (Pryce et al., 2007) are
ﬁrst only in the syndetome, but then they spread within the muscle
mass (Deries et al., 2010). As myocytes move to create the future
epaxial muscles, the connective tissue progenitors cluster at the end
of the myocytes eventually creating the tendon anlagen (Deries et al.,
2010). The connective tissue is therefore a good candidate to act as the
motile force of the movement of the muscle cells. In this hypothesis,
the communication of themyocytes with their environment is crucial,
not only with the cells of the surrounding mesenchyme, but also with
the ECM produced by this connective tissue. Interestingly, the
expression pattern of integrins during the transformation of the
myotome is conspicuous in the fact that the laminin receptors α6β1
and α7β1 integrins cease to be expressed after E11.5 to only reappear
at E13.5 (Cachaço et al., 2005), speciﬁcally at the time when the
translocation of the epaxial myocytes has terminated (Deries et al.,
2010). Furthermore, the laminin-containing basement membrane
separating the myotome from the sclerotome has disappeared by
E11.5 and, although some laminin 211 is detected within the
myotome, this staining is discontinuous (Cachaço et al., 2005). Thus,
it is tempting to hypothesise that myocytes need to detach from their
laminin anchor to be able to move.
In contrast to the laminin receptors, ﬁbronectin receptors integrin
subunits α4, α5 and αv are expressed during the whole transforma-
tion of the myotomes (Cachaço et al., 2005; Hirsch et al., 1994). A
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the muscle masses during morphogenesis of epaxial muscles
(Cachaço et al., 2005). The importance of ﬁbronectin in the
organisation of muscle masses has been pointed out by the knock-
down of ﬁbronectin genes in zebraﬁsh which results in defects in the
alignment and length of myocytes (Snow et al., 2008). Therefore, it is
tempting to suggest that ﬁbronectin may play a role in the
reorganisation of the epaxial myocytes during their morphogenesis.
The glycoprotein tenascin-C is expressed in the sclerotome during
neural crest migration (Riou et al., 1992). It is also known to be present
in tendons, produced by ﬁbroblasts (Chiquet-Ehrismann and Tucker,
2004). Whilst the cleavage planes are forming into myotomes to create
thedistinct epaxialmusclemasses, tenascin-C remainspresentandeven
invades the newly formed gaps (Deries et al., 2010). αvβ3 is a receptor
for tenascin-C and the αv integrin subunit is expressed during this
process (Cachaço et al., 2005; Hirsch et al., 1994). It is enriched at
myotendinous junctions later on (Schwander et al., 2003), suggesting a
potential role for αvβ3-tenascin-C interactions in directing the events.
This hypothesis contradicts the results obtained by inactivating
tenascin-C in mice, as these mutants appear normal (Forsberg et al.,
1996; Saga et al., 1992). However, a thorough investigation at the critical
stages still needs to be done. Another hypothesis is that tenascin-C,
which is part of the ECMpresent around the axialmusclemasses, plays a
role as amechanical force and that the lack of tenascin-C is compensated
by other ECM components such as ﬁbronectin. Interstitial collagens
could also be candidates to provide this mechanical force as they are
present in the sclerotome at these critical stages (Ponticos et al., 2004).
However, it is not clear whether they are then also expressed in the
muscle masses.
The transformation of the hypaxial myotome into the deﬁnitive
muscle masses has barely been investigated. Early researchers
described interlimb hypaxial myotome blending and extending
ventrally into the lateral body wall to create the different layers of
abdominal muscles (Bardeen, 1900; Rizk and Adieb, 1982). Christ
et al. (1983) conﬁrmed the earliest studies by following the hypaxial
dermomyotome and myotome with quail grafts in chick embryos.
They described that the hypaxial lip of the dermomyotome together
with the myotome extend in the lateral abdominal wall. As
mentioned above, the dermomyotome undergoes an epithelium to
mesenchyme transition whilst the myotomes continue to extend
within the ﬂank of the embryo and ﬁnally lose their segmented
structure. The muscle mass then divides into the different layers of
the abdominal muscles and they continue to extend together within
the abdominal wall to reach their ﬁnal position. As muscle masses
segregate and myotubes change their orientation, the connective
tissue invades the cleavage planes in between the layers of muscles.
Cinnamon et al. (1999) used injection of ﬂuorescent vital dyes to
trace the ﬁnal destiny of individual cells injected whilst in the early
myotome at late developmental stages in the quail. They found
marked cells in intercostal muscles, proving that hypaxial myotomal
cells contributed to the formation of intercostal muscle ﬁbres. Thus,
the initial scaffold of intercostal muscles is directly formed from
the hypaxial myotome in situ, showing that myotomal myocytes
need to change their orientation and the hypaxial myotome needs
to segregate to give rise to the three different layers of intercostal
muscles.
The transformation of hypaxial myotome therefore seems to be of
the same nature as that of the epaxial myotome. Since ECM
components and their integrin receptors expression pattern appears
to be the same in the dorsal and the ventral part of the trunk at this
stage (Cachaço et al., 2005) it seems possible that the mechanisms
involved in the transformation of both parts of the myotome are
similar. However, subtle differences could be encountered in the
different parts of the myotome because during earlier stages of
myotome development the cell–ECM adhesion properties epaxially
and hypaxially are different (Bajanca et al., 2004; also see above). Athorough investigation would be necessary to conﬁrm and complete
these theoretical models.
The formation of multinucleated myotubes
The next step inmyogenesis is the differentiation of myogenic cells
into fusion-competent myoblasts and the fusion of these cells into
multinucleated myotubes, which then mature into muscle ﬁbres
(Biressi et al., 2007; Hauschka, 1994; Stockdale, 1992; Wigmore and
Dunglison, 1998;). The early stage muscle masses give rise to three
different populations of myoblasts: primary (also called embryonic),
secondary (also called foetal) and adult (also called satellite cell)
myoblasts (Biressi et al., 2007; Hauschka, 1994; Stockdale, 1992;
Wigmore and Dunglison, 1998). The process by which myotubes are
formed and grow is called primary or secondary myogenesis,
depending on the embryonic stage at which it happens, and the
types of myoblasts involved (Kelly and Zacks, 1969; Ontell and
Kozeka, 1984; Ross et al., 1987). Primary myogenesis starts in the
myotome of the mouse at E11.5 (Fig. 2C) and ends around E14.5. It
involves the fusion of primarymyoblasts tomyotomal myocytes (or to
each other), giving rise to binucleated myotubes, followed by the
fusion of primary myoblasts to those myotubes (Biressi et al., 2007;
Buckingham, 2001; Deries et al., 2010). Primary myogenesis in the
limbs starts about half a day later and ﬁrst involves the fusion of
primary myoblasts to each other and then the fusion of myoblasts to
those myotubes (Biressi et al., 2007; Buckingham, 2001; Christ and
Brand-Saberi, 2002). Most importantly, primary myotubes set the
orientation of all muscles and serve as a scaffold for the remaining
stages of myogenesis (Hauschka, 1994). Secondary myogenesis starts
at around E14.5 in the mouse when secondary myoblasts enter the
myogenic programme and adhere to primary myotubes near
innervations sites and, using the primary myotubes as a scaffold,
fuse with each other giving rise to secondary myotubes (Fig. 2C)
(Duxson et al., 1989; Harris et al., 1989). Notably, secondary
myoblasts also fuse to the ends of primary myotubes, thus
contributing to their growth (Zhang and McLennan, 1995). Here we
will primarily focus on how cell–ECM interactions contribute to the
formation of primary myotubes, the scaffold that sets the direction
and organisation of the muscles to be.
To address how cell–ECM interactions contribute to myotube
formation, focus has been turned to the role of β1 integrins. Since
inactivation of Itgb1 in the mouse leads to a very early lethality
(Fässler and Meyer, 1995; Stephens et al., 1995), not allowing for the
study of the role of β1 integrins in myogenesis, embryo chimaeras
composed of wild-type and Itgb1-null cells were produced. These
revealed normal myotubes composed of a mixture of wild-type and
Itgb1-null nuclei suggesting that Itgb1-null myoblasts can fuse with
wild-type cells (Fässler and Meyer, 1995), raising the question
whether cell–ECM interactions through β1 integrins are necessary
for myotube formation. However, the observation that ES-cell derived
(i.e. primary) Itgb1-null myoblasts showed impaired fusion in vitro,
whereas Itgb1-null secondary myoblasts isolated from late gestation
wild-type/Itgb1-null chimaeras fused normally (Hirsch et al., 1998),
gave the ﬁrst indication that β1 integrins were important at least for
primary myogenesis. Nevertheless, since in vitro culture conditions
tend to be more permissive for fusion than the in vivo environment
(Gullberg et al., 1998; McLennan and Koishi, 2002), further studies
were necessary to conﬁrm these results in vivo. This was addressed by
using a mouse line where the striated muscle speciﬁc β1D splice
variant, normally only expressed in skeletal muscle from E17.5
(Brancaccio et al., 1998; van der Flier et al., 1997), was knocked into
the locus of the ubiquitously expressed β1A variant (Baudoin et al.,
1998). β1D differs from β1A in its cytoplasmic domain and in its
interaction with intracellular effectors such as talins, α-actinin,
ﬁlamins (Belkin et al., 1997; Pfaff et al., 1998) and ILK (Hannigan
et al., 1996), without any effect on ligand speciﬁcity (Belkin et al.,
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revealed a reduction in skeletal muscle mass due to an impairment of
primary myogenesis, evidenced by fewer and smaller primary
myotubes (Cachaço et al., 2003). Interestingly, this effect was speciﬁc
for primary myogenesis since secondary myogenesis proceeded
normally until limited by the availability of primary myotubes
(Cachaço et al., 2003). These results demonstrated that β1A is
essential for the formation of primary myotubes and that β1D is
unable to substitute for β1A in this process. These results also showed
that either β1 integrins are dispensable for secondary myogenesis or
their function is readily performed by β1D. Subsequently, conditional
inactivation of Itgb1 (i.e. both β1A and β1D) with a human skeletal α-
actin Cre, also showed an impairment in primary myogenesis in vivo
with the formation of fewer primary myotubes and an accumulation
of unfused myoblasts (Schwander et al., 2003). Interestingly,
secondary myogenesis was also impaired and an analysis of this
process in vitro, revealed abnormalities in myoblast fusion, costamere
structure and sarcomere maturation, which were not rescued by
conditioned medium from wild-type cultures (Schwander et al.,
2003). Thus, β1 integrins play an essential role in myotube formation
both during primary and secondary myogenesis. Furthermore, the
results of Cachaço et al. (2003) demonstrate that whereas β1A is
essential for primary myogenesis, both β1A and β1D can mediate
cell–ECM interactions during secondary myogenesis.
Although cell–ECM interactions through β1 integrins have been
established as necessary for both primary and secondary myogenesis,
it is still unclear exactly which ligands in the ECM are involved in
these interactions. β1 pairs with 12 different αs, giving rise to
integrins recognising at least 12 different ECM molecules, with
considerable redundancy (see Table 2). However, some cues are
available for primary myogenesis. The two major laminin-binding
integrins of skeletal muscle (α6β1 and α7β1) are absent when
primary myotubes are being formed and a continuous basement
membrane is lacking in both limb and axial muscle masses (Cachaço
et al., 2005; Chiu and Sanes, 1984; Godfrey and Gradall, 1998), arguing
against a role for cell–laminin interactions in the events leading up to
primarymyoblast fusion. However, these integrins are reexpressed on
myotubes after their formation, which correlates with the deposition
of a laminin 211-containing basement membrane around the
myotubes (Cachaço et al., 2005; Chiu and Sanes, 1984; Gullberg
et al., 1998), suggesting a role in myotube maturation and/or stability.
Of the integrin subunits expressed during primarymyotube formation
(α1,α4,α5 andαv), all butα1 are ﬁbronectin receptors (see Table 2),
and ﬁbronectin is present within the early muscle masses at all stages
of primary myogenesis (Cachaço et al., 2005). These observations
suggest a potential role for cell–ﬁbronectin interactions, possibly in
cell alignment in preparation for fusion, as suggested by ﬁbronectin
knock-down in zebraﬁsh (Snow et al., 2008). Inactivation of Itga1
(Gardner et al., 1996) and Itgav (Bader et al., 1998) did not show any
phenotype in skeletal muscle in the mouse and unfortunately, mouse
embryos null for Fn1 (George et al., 1993), Itga4 (Yang et al., 1995,
1999) and Itga5 (Yang et al., 1993, 1999) die too early to address this
issue in vivo. Thus exactly what cell–ECM interactions regulate
primary myotube formation in the embryo is still an open question.
It is well known that the connective tissue around the developing
muscle masses of trunk and limbs plays an essential regulatory role in
their differentiation, subdivision into separatemuscle anlagens, and in
the orientation of primary myotubes within those anlagens (Brent
et al., 2003; Chevallier et al., 1977; Christ et al., 1977; Deries et al.,
2010; Hurle et al., 1990; Kardon, 1998;Mathew et al., 2011; Shellswell
et al., 1980; also see The translocation of the myotome section). For
example, it was recently proved that ﬁbroblasts of muscle connective
tissue expressing the transcription factor Tcf4 are needed to regulate
foetal myogenesis (Mathew et al., 2011). The inactivation of Tcf4 leads
to the reduction of the proportion of slow ﬁbres and an increase of
embryonic ﬁbres in limb muscles. Moreover, the loss of Tcf4-expressing ﬁbroblasts results in reduction of slow MHC. These results
strongly suggest that muscle ﬁbroblasts promote the maturation of
myoﬁbres. This regulation is both dependent and independent of Tcf4
and might act through the regulation of cell–ECM interactions. In fact,
dynamic changes in ECM composition occur during these events
(Fernandez et al., 1991; Olguin and Brandan, 2001) but much is yet to
be known about the speciﬁc ECM molecules within the connective
tissue and the cell–ECM interactions involved in the shaping of the
early muscle masses (Edom-Vovard and Duprez, 2004; Evans et al.,
2006). Nevertheless, it is clear that the failure of muscle ﬁbres to
connect to the ECM of developing tendons during development, leads
to their apoptosis (Rodriguez-Guzman et al., 2007). The increased
apoptosis seen in the muscle masses of β1D knock-in embryos
(Cachaço et al., 2003) could be due to the failure of the short
myoﬁbres to establish tendon connections and cell detachment from
tendons was indeed observed in muscles lacking β1 integrins
(Schwander et al., 2003). Interestingly, activation and inhibition of
retinoic acid signalling contributes to the shaping of muscles by
inﬂuencing their attachment to the ECM, where retinoic acid
signalling downregulates β1 integrins, thus causing myoﬁbre detach-
ment and apoptosis (Rodriguez-Guzman et al., 2007). The challenge
ahead is to dissect out exactly what cell–ECM interactions are
involved in these phenomena and to learn more about how the
connective tissue ECM orients and shapes skeletal muscles.
Future perspectives
The ECM is now established as an essential player in skeletal muscle
development. However, many gaps in our knowledge still remain. A
fascinating area to address further is how cell–ECM interactions
contribute towards regulating the precise equilibrium between self-
renewing cells and the phased induction of myogenic commitment in
the dermomyotome. Another area that merits further study is which
ECMmolecules and integrin receptors are involved in the translocation
of MPCs and differentiated myocytes. In the case of MPCs, do they use
multiple ECM molecules and multiple integrins or do they require a
speciﬁc substrate on their migration path? In the case of the
translocation of differentiated cells, do they actively migrate, or do
they attach to key points in the ECM and become “displaced” to a
different location by mechanical forces within the changing environ-
ment? Potential differences in the events leading up to the formation of
primary versus secondary myotubes is also a fascinating subject to
address. Primary myoblasts fuse in an environment composed of an
interstitial ECM, whereas secondary myoblasts use primary myotubes
(and potentially also their basement membrane) as a scaffold for their
alignment and fusion. It will be interesting to dissect out how these
distinct environments differ in terms of cell–ECM interactions and how
each promotes myotube formation. Finally, although not the subject of
this review, it is also urgent to understand how cell–ECM interactions
contribute to adult myogenesis and muscle repair, which has clear
applications for designing therapies for muscle dystrophies. Do cell–
ECM interactions contribute to maintain muscle precursors within the
muscle stem cell niche and how do those cell–ECM interactions change
upon activation, proliferation and differentiation of the muscle satellite
cells into fusion-competent myoblasts? Can we learn from the
“dermomyotome niche” or are the programmes of the adult “muscle
stem cell niche” different? Further investment into studying the ECM
dimension of skeletal muscle development in the embryo will certainly
provide a fuller understanding of embryonic myogenesis. The knowl-
edge obtained can then be applied to the study of adult myogenesis and
the treatment of muscle dystrophies.
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